DOH lifts suspension of AstraZeneca jabs

SunStar
(File)
May 07, 2021
THE Department of Health (DOH) on Friday, May 7, 2021, announced the resumption of vaccinations using the Oxford AstraZeneca vaccine ahead of the expected delivery of two million doses within the month.
The agency said guidelines on the management of adverse events following immunization (AEFI), particularly for the very rare vaccine-induced thrombosis and thrombocytopenia (VITT), have been updated.
VITT is a very rare condition of blood clots associated with low platelet counts that can occur 4 to 28 days after receiving a viral vector vaccine such as AstraZeneca, DOH said in a statement Friday.
Vaccinations using the AstraZeneca vaccine were halted for individuals below 60 years old on April 8 because of recent reports of very rare cases of blood clots.

Related Keywords

Philippines ,Philippine ,Benguet ,Oxford Astrazeneca ,Astrazeneca ,Experts Group On Vaccines ,Philippine College Of Hematology ,National Adverse Events Following Immunization Committee ,Department Of Health ,Drug Administration ,All Experts Group ,Philippine College ,Transfusion Medicine ,Marites Villamor Ilano ,Sunstar Philippines ,பிலிப்பைன்ஸ் ,பிலிப்பைன் ,பிலிப்பைன் கல்லூரி ஆஃப் ஹீமாட்டாலஜி ,துறை ஆஃப் ஆரோக்கியம் ,பிலிப்பைன் கல்லூரி ,பரிமாற்றம் மருந்து ,சன்ஸ்டார் பிலிப்பைன்ஸ் ,